Unusual norovirus and rotavirus genotypes in Ethiopia

Paediatrics and International Child Health

Volumn 32, Issue 1, 2012, Pages 51-55

  Yassin, Mohammed A ^a   Kirby, Andrew ^b   Mengistu, Abebayehu A ^a   Arbide, Isabel ^c   Dove, Winifred ^b   Beyer, Mandy ^b   Cunliffe, Nigel A ^b   Cuevas, Luis E ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c Bushullo Health Centre   (Ethiopia)

Author keywords

Children; Diarrhoea; Ethiopia; Norovirus; Rotavirus

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CHILD; CHILD HEALTH; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEHYDRATION; DIARRHEA; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; NEWBORN; NONHUMAN; NOROVIRUS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; REHYDRATION; ROTAVIRUS; SEQUENCE ANALYSIS; SEX DIFFERENCE; VIRAL GASTROENTERITIS; VIRUS DETECTION; VIRUS STRAIN; VOMITING; CALICIVIRUS INFECTION; DNA SEQUENCE; GASTROENTERITIS; GENETICS; ISOLATION AND PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS INFECTION; VIROLOGY;

CALICIVIRIDAE INFECTIONS; CROSS-SECTIONAL STUDIES; DIARRHEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; GASTROENTERITIS; GENOTYPE; HUMANS; INFANT; MALE; MOLECULAR EPIDEMIOLOGY; NOROVIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEQUENCE ANALYSIS, DNA;

EID: 84865301206     PISSN: 20469047     EISSN: 20469055     Source Type: Journal    
DOI: 10.1179/1465328111Y.0000000047     Document Type: Article

References (22)

1. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006;12:304-6.
2. Koopmans M. Progress in understanding norovirus epidemiology. Curr Opin Infect Dis. 2008;21:544-52.
3. O'Ryan M. The ever-changing landscape of rotavirus serotypes. Pediatr Infect Dis J. 2009;28 (suppl. 3): S60-2.
4. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. Norovirus classification and proposed strain nomenclature. Virology. 2006;346:312-23.
5. Siebenga JJ, Vennema H, Renckens B, de Bruin E, van der Veer B, Siezen RJ, et al. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol. 2007;81:9932-41.
6. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009;200 (suppl 1):S9-15.
7. Mwenda JM, Ntoto KM, Abebe A, Enweronu-Laryea C, Amina I, Mchomvu J, et al. Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance Network. J Infect Dis. 2010;202 (suppl): S5-11.
8. World Health Organization. Diarrhoea Treatment Guidelines 2005. http://whqlibdoc.who.int/publications/2005/a85500.pdf.
9. Das BK, Gentsch JR, Cicirello HG, Woods PA, Gupta A, Ramachandran M, et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol. 1994;32:1820-2.
10. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol. 1992;30:1365-73.
11. Kirby A, Dove W, Ashton L, Hopkins M, Cunliffe NA. Detection of norovirus in mouthwash samples from patients with acute gastroenteritis. J Clin Virol. 2010;48:285-7.
12. Kojima S, Kageyama T, Fukushi S, Hoshino FB, Shinohara M, Uchida K, et al. Genogroup-specific PCR primers for detection of Norwalk-like viruses. J Virol Methods. 2002;100:107-14.
13. Todd S, Page NA, Duncan Steele A, Peenze I, Cunliffe NA. Rotavirus strain types circulating in Africa: Review of studies published during 1997-2006. J Infect Dis. 2010;202 (suppl): S34-42.
14. Kirkwood CD, Coulson BS, Bishop RF. G3P2 rotaviruses causing diarrhoeal disease in neonates differ in VP4, VP7 and NSP4 sequence from G3P2 strains causing asymptomatic neonatal infection. Arch Virol. 1996;141:1661-76.
15. Barnes GL, Lund JS, Mitchell SV, De Bruyn L, Piggford L, Smith AL, et al. Early phase II trial of human rotavirus vaccine candidate RV3. Vaccine. 2002;20:2950-6.
16. Tate JE, Patel MM, Steele AD, Duncan A, Gentsch JR, Payne DC, et al. Global impact of rotavirus vaccines. Expert Rev Vaccines. 2010;9:395-407.
17. Barreira DM, Ferreira MS, Fumian TM, Checon R, de Sadovsky AD, Leite JP, et al. Viral load and genotypes of noroviruses in symptomatic and asymptomatic children in Southeastern Brazil. J Clin Virol. 2010;47:60-4.
18. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis. 2008;14:1553-7.
19. Bucardo F, Nordgren J, Carlsson B, Paniagua M, Lindgren PE, Espinoza F, et al. Pediatric norovirus diarrhea in Nicaragua. J Clin Microbiol. 2008;46:2573-80.
20. Siebenga JJ, Vennema H, ZhengDP, Vinjé J, LeeBE, PangXL, et al. Norovirus illness is a global problem: emergence and spread of Norovirus GII.4 variants, 2001-2007. J Infect Dis. 2009;200:802-12.
21. Yoon JS, Lee SG, Hong SK, Lee SA, Jheong WH, Oh SS, et al. Molecular epidemiology of norovirus infections in children with acute gastroenteritis in South Korea in November 2005 through November 2006. J Clin Microbiol. 2008;46:1474-7.
22. AllenDJ, Noad R, Samuel D, Gray JJ, Roy P, Iturriza-GomaraM. Characterisation of a GII-4 norovirus variant-specific surfaceexposed site involved in antibody binding. Virol J. 2009;6:150.